116 related articles for article (PubMed ID: 38849860)
1. Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer.
Liang Y; Ye F; Luo D; Long L; Wang Y; Jin Y; Wang L; Li Y; Han D; Chen B; Zhao W; Wang L; Yang Q
Mol Cancer; 2024 Jun; 23(1):125. PubMed ID: 38849860
[TBL] [Abstract][Full Text] [Related]
2. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
3. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
4. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
[TBL] [Abstract][Full Text] [Related]
6. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
7. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
[TBL] [Abstract][Full Text] [Related]
8. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
[TBL] [Abstract][Full Text] [Related]
9. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.
Pan Z; Zhao R; Li B; Qi Y; Qiu W; Guo Q; Zhang S; Zhao S; Xu H; Li M; Gao Z; Fan Y; Xu J; Wang H; Wang S; Qiu J; Wang Q; Guo X; Deng L; Zhang P; Xue H; Li G
Mol Cancer; 2022 Jan; 21(1):16. PubMed ID: 35031058
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1.
Lin J; Wang X; Zhai S; Shi M; Peng C; Deng X; Fu D; Wang J; Shen B
J Hematol Oncol; 2022 Sep; 15(1):128. PubMed ID: 36068586
[TBL] [Abstract][Full Text] [Related]
12. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
[TBL] [Abstract][Full Text] [Related]
13. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway.
Zan X; Li W; Wang G; Yuan J; Ai Y; Huang J; Li Z
Reprod Biol Endocrinol; 2022 Sep; 20(1):138. PubMed ID: 36109751
[TBL] [Abstract][Full Text] [Related]
14. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
15. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.
Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H
Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246
[No Abstract] [Full Text] [Related]
16. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer.
Romero-Cordoba SL; Rodriguez-Cuevas S; Bautista-Pina V; Maffuz-Aziz A; D'Ippolito E; Cosentino G; Baroni S; Iorio MV; Hidalgo-Miranda A
Sci Rep; 2018 Aug; 8(1):12252. PubMed ID: 30115973
[TBL] [Abstract][Full Text] [Related]
17. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis.
Yang J; Zhang X; Cao J; Xu P; Chen Z; Wang S; Li B; Zhang L; Xie L; Fang L; Xu Z
Cell Death Dis; 2021 Oct; 12(10):910. PubMed ID: 34611143
[TBL] [Abstract][Full Text] [Related]
20. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]